Patents Assigned to Galeotin Therapeutics, Inc.
  • Patent number: 9872909
    Abstract: Methods and compositions of the invention relate to the enhancement of specific immunotherapies in cancer treatment. In particular, aspects of the invention relate to novel approaches to boost immune function using a complex carbohydrate pharmaceutical compound alone or in combination with other targeted immunotherapy to increase the efficacy of immunotherapy of cancer.
    Type: Grant
    Filed: September 17, 2013
    Date of Patent: January 23, 2018
    Assignees: Galeotin Therapeutics, Inc., Providence Health & Services—Oregon
    Inventors: Peter G. Traber, William L. Redmond, Eliezer Zomer, Anatole Klyosov, Stefanie N. Linch